The goal of this activity is for learners to be better able to understand the implications of the latest clinical trial data investigating PARP inhibitor combinations in mCRPC and apply the latest recommendations for managing patients using these combinations.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org
- Start Date: 2025-02-28 06:00:00
- End Date: 2025-02-28 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - Commercial Support: Source: Pfizer - Amount: 194122.0 - Is Kind Support: False
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest